In a new study, researchers modeled the transmission of Clostridioides difficile (C. diff) infections among patients in ...
A new study on Clostridioides difficile infections finds that choosing an alternative antibiotic for high-risk patients with pneumonia can reduce infection risk. C. diff infections can be deadly, and ...
Findings published in the American Journal of Infection Control could help reduce clinical and economic impact of common and serious HAIs Arlington, Va., January 20, 2022 – New data published today ...
VA study finds a 45% reduction in Clostridioides difficile infections among high-risk patients with the use of doxycycline instead of azithromycin For patients who are admitted to a hospital with ...
Hospital-acquired infections can cause severe complications in cancer patients, and C. diff is one of the most common.
Affecting roughly half a million Americans each year, bacterial infections caused by Clostridioides difficile—commonly known as C. diff—are a serious and persistent problem for patients and hospitals ...
Iron storage "spheres" inside the bacterium C. diff—the leading cause of hospital-acquired infections—could offer new targets for antibacterial drugs to combat the pathogen. A team of Vanderbilt ...
Take 5 minutes to catch up on Infection Control Today’s highlights for the week ending March 25. Here are 6 highlights from ICT®â€™s wide-ranging coverage of the infection prevention and control world.
Take 5 minutes to catch up on Infection Control Today’s highlights for the week ending May 6. Here are 5 highlights from ICT®â€™s wide-ranging coverage of the infection prevention and control world.
Newly discovered iron storage 'ferrosomes' inside the bacterium C. diff -- the leading cause of hospital-acquired infections -- are important for infection in an animal model and could offer new ...
New data published today suggest that several commonly used machine learning algorithms (MLAs) can effectively predict which hospitalized patients will become infected with Clostridiodes difficile (C.